93 related articles for article (PubMed ID: 6976920)
1. Inhibition of activated factors II, VII, IX, and X by synthetic organic compounds directed against the active-site seryl residue.
Van der Woerd-de Lange JA; van Dam-Mieras MC; Hemker HC
Haemostasis; 1981; 10(6):315-47. PubMed ID: 6976920
[TBL] [Abstract][Full Text] [Related]
2. The effect of antithrombin III on the activity of the coagulation factors VII, IX and X.
Osterud B; Miller-Andersson M; Abildgaard U; Prydz H
Thromb Haemost; 1976 Apr; 35(2):295-304. PubMed ID: 61631
[TBL] [Abstract][Full Text] [Related]
3. Protection of platelet surface bound factors IXa and VIII against specific inhibitors.
Váradi K; Elödi S
Thromb Haemost; 1982 Feb; 47(1):32-5. PubMed ID: 6978548
[TBL] [Abstract][Full Text] [Related]
4. [Effect of nitro-- derivatives of warfarin on blood coagulation].
Lakin KM; Smirnova TV; Karaseva MG; Fel'dbaum VA
Farmakol Toksikol; 1967; 30(4):456-60. PubMed ID: 5598901
[No Abstract] [Full Text] [Related]
5. Activation of human factor VII by activated factors IX and X.
Masys DR; Bajaj SP; Rapaport SI
Blood; 1982 Nov; 60(5):1143-50. PubMed ID: 7126868
[TBL] [Abstract][Full Text] [Related]
6. The role of factor VII in the intrinsic pathway: a brief review.
Prydz H
Haemostasis; 1983; 13(3):156-60. PubMed ID: 6350120
[TBL] [Abstract][Full Text] [Related]
7. The anticoagulant activity of 3-1-phenyl-propyl-4-hydroxycoumarin in patients on "long-term" therapy.
Bourgain RH; Vanden Driessche R; Smets P
Arch Int Pharmacodyn Ther; 1972 Feb; 195(2):240-6. PubMed ID: 5015934
[No Abstract] [Full Text] [Related]
8. Regulation of factor IXa in vitro in human and mouse plasma and in vivo in the mouse. Role of the endothelium and the plasma proteinase inhibitors.
Fuchs HE; Trapp HG; Griffith MJ; Roberts HR; Pizzo SV
J Clin Invest; 1984 Jun; 73(6):1696-703. PubMed ID: 6202716
[TBL] [Abstract][Full Text] [Related]
9. p-Amidino esters as irreversible inhibitors of factors IXa and Xa and thrombin.
Turner AD; Monroe DM; Roberts HR; Porter NA; Pizzo SV
Biochemistry; 1986 Aug; 25(17):4929-35. PubMed ID: 3490273
[TBL] [Abstract][Full Text] [Related]
10. A coagulation pathway on bovine aortic segments leading to generation of Factor Xa and thrombin.
Stern DM; Nawroth PP; Kisiel W; Handley D; Drillings M; Bartos J
J Clin Invest; 1984 Dec; 74(6):1910-21. PubMed ID: 6439737
[TBL] [Abstract][Full Text] [Related]
11. [Anticoagulant of indirect action nitropharin].
Lakin KM; Smirnova TV; Karaseva MG
Farmakol Toksikol; 1968; 31(2):184-7. PubMed ID: 5674673
[No Abstract] [Full Text] [Related]
12. Nontoxic irreversible inhibitors of factors IXa, Xa, and thrombin: potential therapeutic agents for the in vivo regulation of thrombin generation and activity.
Pizzo SV; Turner AD; Gonias SL; Monroe DM; Roberts HR; Porter NA
Ann N Y Acad Sci; 1986; 485():199-203. PubMed ID: 3494415
[No Abstract] [Full Text] [Related]
13. Regulation of the initiation of coagulation by factor VII.
Nemerson Y
Haemostasis; 1983; 13(3):150-5. PubMed ID: 6350119
[TBL] [Abstract][Full Text] [Related]
14. The dual role of factor VII in blood coagulation. Initiation and inhibition of a proteolytic system by a zymogen.
Zur M; Radcliffe RD; Oberdick J; Nemerson Y
J Biol Chem; 1982 May; 257(10):5623-31. PubMed ID: 6978336
[No Abstract] [Full Text] [Related]
15. Assembly of the intrinsic factor X activating complex--interactions between factor IXa, factor VIIIa and phospholipid.
van Dieijen G; van Rijn JL; Govers-Riemslag JW; Hemker HC; Rosing J
Thromb Haemost; 1985 Jun; 53(3):396-400. PubMed ID: 3931288
[TBL] [Abstract][Full Text] [Related]
16. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
Lämmle B; Griffin JH
Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
[TBL] [Abstract][Full Text] [Related]
17. [Blood coagulation mechanism from the viewpoint of molecular biochemistry: Activation of coagulation in phospholipid phase].
Suzuki K
Rinsho Byori; 1985 Sep; 33(9):966-73. PubMed ID: 3878417
[No Abstract] [Full Text] [Related]
18. Coagulation factor IX residues G4-Q11 mediate its interaction with a shared factor IX/IXa binding site on activated platelets but not the assembly of the functional factor X activating complex.
Ahmad SS; Wong MY; Rawala R; Jameson BA; Walsh PN
Biochemistry; 1998 Feb; 37(6):1671-9. PubMed ID: 9484238
[TBL] [Abstract][Full Text] [Related]
19. STUDIES ON PROCONVERTIN (FACTOR VII) II. PURIFICATION.
PRYDZ H
Scand J Clin Lab Invest; 1964; 16():101-7. PubMed ID: 14124442
[No Abstract] [Full Text] [Related]
20. Engineered recombinant factor VII Q217 variants with altered inhibitor specificities.
Chang YJ; Hamaguchi N; Chang SC; Ruf W; Shen MC; Lin SW
Biochemistry; 1999 Aug; 38(34):10940-8. PubMed ID: 10460149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
